Navigation Links
Thermal Angel Supports Infection Control During the Golden Hour
Date:4/27/2009

DALLAS, April 27 /PRNewswire/ -- Estill Medical Technologies, Inc., the industry leader in portable blood and IV fluid warming therapy, announces the expansion of its Thermal Angel sales and marketing efforts. The Thermal Angel reduces the chance of mortality by quickly controlling core body temperature and infection risk.

The Thermal Angel is crucial to critical care administration. In emergency medicine, the golden hour refers to the first 60 minutes after the occurrence of a multi-system trauma. It is widely believed that the victim's survival chances are greatest if they receive definitive care within this first hour of injury.

So, how does the Thermal Angel work? It is portable, battery-powered, and disposable. It warms IV fluid and blood and is capable of initiating intravenous application within 45 seconds. It also prevents fluid-induced hypothermia, which can create numerous life-threatening conditions.

"Due to its portable and adaptive nature," Jay Lopez, president of Estill Medical Technologies, Inc. says, "we've had 93 countries request the Thermal Angel, but our primary focus has been to provide supplies for our military troops."

A platoon medic with the U.S. Army Ranger Regiment explains that, "The Thermal Angel Blood and IV Infusion Warmer is an excellent piece of medical equipment; it's essential to our deployment packing list. It's compact, lightweight, and easy to use."

A military medic must be economical in his choice of equipment and the Thermal Angel is cost efficient and requires minimal time for charging and operation. And, because the Thermal Angel is disposable, infection control becomes much more manageable. It also provides peace of mind should unexpected situations such as delays occur.

"As a result of the success our military has had using the Thermal Angel in medical field kits, on Black Hawk helicopters, and in ground vehi
'/>"/>

SOURCE Estill Medical Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. ANSYS and Network Analysis Team Up to Improve Thermal Simulation
2. UltraShape(R) Commences Pivotal Study for First Non-Invasive Fat Reduction and Body Contouring Device Using Non-Thermal Selective Focused Ultrasound
3. How to enhance non-thermal effects of ultrasound
4. Lab Series(R) Skincare For Men Spa Indulges the 2007 Primetime Emmy(R) Nominees at the Sofitel(R) Los Angeles
5. Alzheimers Foundation of America to Display Quilt to Remember in Los Angeles
6. Nautica Malibu Triathlon Presented by Toyota Raises $718,000 for Childrens Hospital Los Angeles Pediatric Cancer Research
7. Fifth Annual Avon Walk for Breast Cancer Los Angeles Raises $4.3 Million
8. British Council and Los Angeles Area Universities Partner to Host Transatlantic Dialogues
9. Los Angeles Area Chamber of Commerce Endorses Governor Schwarzeneggers Health Care Proposal
10. Lauren Marangell, M.D. to Join Lilly; Internationally Recognized Expert in Depression Joins as Distinguished Lilly Scholar
11. Angel Flight West Recognizes Colorado Pilots and Supporters at AFW 24th Anniversary Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... Final Cut Pro X plugin ... from Pixel Film Studios. , “The TranStatic Volume 2 plugin ... Christina Austin, CEO of Pixel Film Studios. “TranStatic Volume 2 ... Pro X editors toolbox.” , With TranStatic Volume 2 users ... altering static scrambling effects from Pixel Film Studios. Users have ...
(Date:3/1/2015)... (PRWEB) March 02, 2015 ... services and manage their practices compliantly and ... integrated all-inclusive solution. The interoperability between ... and a medical practice management system is ... long-term financial sustainability. A referral management and ...
(Date:3/1/2015)... (PRWEB) March 02, 2015 As ... web works co-founders, Michael Burns and Carita Weaver, ... addition to working with the Southlake Chamber of ... i5 web works recently launched a website for ... , A primary communications tool for Hill’s campaign, ...
(Date:3/1/2015)... Birmingham, Clarkston, Lake Orion, Metamora, Michigan (PRWEB) March 01, 2015 ... BOTOX® , which is approved to treat Overactive Bladder (OAB) ... urgency and frequency in adults when another type of medication ... This is a different treatment option that takes another ... itself. , BOTOX® works on the nerves and ...
(Date:3/1/2015)... (PRWEB) March 01, 2015 Adults who ... insurance rates for term or universal policies can now ... of the best life insurance companies for single adults ... system at http://quotespros.com/life-insurance.html . , The rate plans ... portal are tied to a number of life protection ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios released the TranStatic Volume 2 plugin for Final Cut Pro X today 2Health News:Power Up Physician and Patient Referral Management While Qualifying for ARRA Incentives 2Health News:Power Up Physician and Patient Referral Management While Qualifying for ARRA Incentives 3Health News:Power Up Physician and Patient Referral Management While Qualifying for ARRA Incentives 4Health News:Website Launched for Southlake, Texas Mayoral Candidate Laura Hill 2Health News:Women's Excellence Now Offers BOTOX For Overactive Bladder Treatment 2Health News:Best Life Insurance Companies for Single Adults Now Searchable at Insurance Website 2
... Experience with Complex Rehab Market , , ... rehab specialist with 35 years of experience, has joined ... fastest growing complex rehab companies. O,Neill is an Assistive ... www.alliance-seating.com ) and is responsible for sales and service of ...
... muscular atrophy, a neurodegenerative disorder that causes the weakening ... and occurs in 1 in 6,000 live births. ... impressive results as a treatment for spinal muscular atrophy ... to translate the therapy to the human body. A ...
... Mo. Evolving HIV viral strains and the adverse ... treatments propel scientists to continue exploring alternative HIV ... Missouri researcher has identified broad-spectrum aptamers. Aptamers are ... reproducing. In lab tests, aptamers known as RT5, ...
... TriCipher will host an,informative Webinar detailing ... pharmaceutical and health care industries and strategies,for securing ... one hour webinar on December 16th brings together ... discuss how digital signatures have,benefited and streamlined research ...
... of voriconazole in combating fungal infections has been confirmed ... International Journal of Antimicrobial Agents ( www.elsevier.com/locate/ijaa ... with weakened immune systems, which can be caused by ... reinforces earlier findings that this drug is a potent ...
... Dec. 16 WellPoint, Inc. (NYSE: WLP ... today,announced plans to collaboratively partner with four Blue Cross ... to online, consumer-friendly,health care cost information. , ... WellPoint in this initiative are,Highmark Inc. (Pennsylvania), Premera Blue ...
Cached Medicine News:Health News:Veteran Rehab Specialist, Ted O'Neill, Joins Fast-Growing Alliance Seating & Mobility in Pennsylvania 2Health News:Researcher refining synthetic molecules to prevent HIV resistance 2Health News:Pharmaceutical and Health Care Experts to Detail Cost-Cutting Capabilities of Secure Digital Signatures 2Health News:Pharmaceutical and Health Care Experts to Detail Cost-Cutting Capabilities of Secure Digital Signatures 3Health News:Voriconazole: A highly potent treatment for fungal infections 2Health News:WellPoint Announces Collaborative Partnership to Expand Access to Health Care Provider Information 2Health News:WellPoint Announces Collaborative Partnership to Expand Access to Health Care Provider Information 3Health News:WellPoint Announces Collaborative Partnership to Expand Access to Health Care Provider Information 4
(Date:2/27/2015)... MARLTON, N.J. , Feb. 27, 2015  Acsis ... collaboration and serialization solutions, announced today that John ... as a Supply & Demand Chain Executive ... chain executives who are leading initiatives to help prepare ... challenges of today,s business climate. This year,s list of ...
(Date:2/27/2015)... 2015 Isis Pharmaceuticals, Inc. (Nasdaq: ... pro forma net operating loss (NOL) guidance and its ... position.  Isis, significantly improved financial results were due in ... payments the Company received from its partners.  Isis, pro ... nearly 60% improvement over its 2013 NOL of $40.2 ...
(Date:2/27/2015)... 2015 Report Details   ... trends, R&D progress, and predicted revenues ,Where is the ... the commercial prospects for this market and related technologies? ... other trends to 2025, discussing data, opportunities and prospects. ... regenerative medicine : cell-based therapies that aim to ...
Breaking Medicine Technology:Acsis CSO John DiPalo Named Supply & Demand Chain Executive 2015 Pro to Know 2Isis Reports Financial Results and Highlights for 2014 2Isis Reports Financial Results and Highlights for 2014 3Isis Reports Financial Results and Highlights for 2014 4Isis Reports Financial Results and Highlights for 2014 5Isis Reports Financial Results and Highlights for 2014 6Isis Reports Financial Results and Highlights for 2014 7Isis Reports Financial Results and Highlights for 2014 8Isis Reports Financial Results and Highlights for 2014 9Isis Reports Financial Results and Highlights for 2014 10Isis Reports Financial Results and Highlights for 2014 11Isis Reports Financial Results and Highlights for 2014 12Isis Reports Financial Results and Highlights for 2014 13Isis Reports Financial Results and Highlights for 2014 14Isis Reports Financial Results and Highlights for 2014 15Isis Reports Financial Results and Highlights for 2014 16Isis Reports Financial Results and Highlights for 2014 17Translational Regenerative Medicine: Market Prospects 2015-2025 2Translational Regenerative Medicine: Market Prospects 2015-2025 3Translational Regenerative Medicine: Market Prospects 2015-2025 4Translational Regenerative Medicine: Market Prospects 2015-2025 5Translational Regenerative Medicine: Market Prospects 2015-2025 6Translational Regenerative Medicine: Market Prospects 2015-2025 7Translational Regenerative Medicine: Market Prospects 2015-2025 8
... May 10, 2011 Omeros Corporation (NASDAQ: ... and commercializing products focused on inflammation, coagulopathies and disorders ... results for the first quarter of 2011. ... ended March 31, 2011 were $7.7 million compared to ...
... 2011 Pierrel Research USA, Inc. ( www.pierrel-research-usa.com ... global pharmaceutical services company ( www.pierrel.it ), announces ... with epinephrine 1:100,000 and Articaine hydrochloride 4% with ... of Articaine with epinephrine, an injectable dental anesthetic ...
Cached Medicine Technology:Omeros Corporation Reports First Quarter 2011 Financial Results 2Omeros Corporation Reports First Quarter 2011 Financial Results 3Omeros Corporation Reports First Quarter 2011 Financial Results 4Pierrel Research USA Launches Orabloc™ a New Purer Articaine 2Pierrel Research USA Launches Orabloc™ a New Purer Articaine 3
For the detection of pan specific pLDH, utilizing whole blood samples. Parabank excludes infected blood from the blood supply in the blood bags....
192 Test Enzyme Immunoassay for the detection of Human IgG antibodies to all four forms of Malaria....
ADVANTAGE MALARIA STIX is a visual, rapid and sensitive immunoassay for the qualitative differential detection of P.falciparum (P.f) and P.vivax (P.v) malaria in Human Blood only....
Malaria device / strip (2 line, PAN specific-pLDH)...
Medicine Products: